🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Cara Therapeutics, Inc.

Cara Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

KORSUVA (difelikefalin)

Cara Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing treatments for pruritus and pain by targeting kappa opioid receptors. Their leading product, KORSUVA, is aimed at treating pruritus associated with chronic kidney disease in hemodialysis patients.

Tags: biopharmaceutical, chronic kidney disease, hemodialysis, kappa opioid receptors, pain management, pruritus

Website

About | About | Management | Directors | About | Contact | ESG | Careers | Careers | About | About | About | About

Symbol: CARA

Recent Price: $0.35

Industry: Biotechnology

CEO: Mr. Christopher A. Posner

Sector: Healthcare

Employees: 55

Address: 4 Stamford Plaza, Stamford, CT 06902

Phone: 203 406 3700

Leadership

  • Martin Vogelbaum, Chairman
  • Christopher Posner, Chief Executive Officer, President, and Director
  • Susan Shiff, Ph.D., Director
  • Jeffrey L. Ives, Ph.D., Director
  • Lisa von Moltke, M.D., Director
  • Helen M. Boudreau, Director

Last updated: 2024-12-31